These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 4189378)

  • 1. [Animal experiment methods for the testing of fibrinolytic and antifibrinolytic agents].
    Klöcking HP; Markwardt F
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1969; 92(1):84-9. PubMed ID: 4189378
    [No Abstract]   [Full Text] [Related]  

  • 2. [Animal experimental studies of the effect of synthetic antifibrinolytics].
    Markwardt F; Klöcking HP
    Acta Biol Med Ger; 1966; 17(6):746-54. PubMed ID: 5990894
    [No Abstract]   [Full Text] [Related]  

  • 3. Studies on the mechanism of action of synthetic antifibrinolytics. A comparison with the action of derivatives of benzamidine on the fibrinolytic process.
    Landmann H
    Thromb Diath Haemorrh; 1973 May; 29(2):253-75. PubMed ID: 4271586
    [No Abstract]   [Full Text] [Related]  

  • 4. [Comparative clinical-pharmacological studies on synthetic antifibrinolytic agents].
    Markwardt F; Klöcking HP; Landmann H
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1969; 92(1):78-83. PubMed ID: 4189376
    [No Abstract]   [Full Text] [Related]  

  • 5. On the action mechanism of some fibrinolysis inhibitors.
    Donner L; Housková J
    Thromb Diath Haemorrh; 1967 Dec; 18(3-4):439-46. PubMed ID: 4952977
    [No Abstract]   [Full Text] [Related]  

  • 6. [Antiplasmins].
    Enache F; Cecil P
    Med Interna (Bucur); 1970 Jun; 22(6):667-76. PubMed ID: 4917257
    [No Abstract]   [Full Text] [Related]  

  • 7. [On the cardiovascular effects of some antifibrinolytic drugs (Trasylol, epsilon-aminocaproic acid, tranexamic acid)].
    Marmo E; Ungaro B; Giordano L
    Minerva Cardioangiol; 1971 Feb; 19(2):86-115. PubMed ID: 4396734
    [No Abstract]   [Full Text] [Related]  

  • 8. Inhibition of coagulation and fibrinolysis by aromatic amidino compounds. An in vitro and in vivo study.
    Geratz JD
    Thromb Diath Haemorrh; 1971 Jun; 25(3):391-404. PubMed ID: 5314899
    [No Abstract]   [Full Text] [Related]  

  • 9. [Inhibitor of fibrinolysis from pancreas pantrypin].
    Lakin KM; Efimov VS; Polonskaia LB
    Farmakol Toksikol; 1969; 32(6):712-5. PubMed ID: 5381603
    [No Abstract]   [Full Text] [Related]  

  • 10. Cardiovascular effects of antifibrinolytic drugs.
    Marmo E; Di Nola R; Rossi F
    Res Commun Chem Pathol Pharmacol; 1973 Jul; 6(1):137-50. PubMed ID: 4542597
    [No Abstract]   [Full Text] [Related]  

  • 11. [On the role of basophilic leukocytes and mast cells in fibrinolysis and allergy. I. Effect of fibrinolytic and antifibrinolytic agents on the degranulation degree of basophilic leukocytes].
    Frick G; Frick U
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1966; 86(4):389-403. PubMed ID: 4168276
    [No Abstract]   [Full Text] [Related]  

  • 12. 4-aminomethylbicyclo[2.2.2]-octane-1-carboxylic acid a new potent antifibrinolytic agent. Its evaluation by in vitro assay procedures.
    Baumgarten W; Priester LI; Stiller DW; Duncan AE; Ciminera JL; Loeffler LJ
    Thromb Diath Haemorrh; 1969 Nov; 22(2):263-72. PubMed ID: 5380948
    [No Abstract]   [Full Text] [Related]  

  • 13. [On the effect of a new synthetic inhibitor of the fibrinolytic system].
    Fischer M; Pavlu C
    Arzneimittelforschung; 1966 May; 16(5):671-3. PubMed ID: 6014440
    [No Abstract]   [Full Text] [Related]  

  • 14. [p-Aminomethylbenzoic acid (PAMBA), a new antifibrinolytic agent. Experimental animal studies].
    Markwardt F; Klöcking HP
    Munch Med Wochenschr; 1965 Oct; 107(41):2000-2. PubMed ID: 5898921
    [No Abstract]   [Full Text] [Related]  

  • 15. Fibrinogen turnover and drugs acting on fibrinolysis.
    De Nicola P
    Acta Univ Carol Med Monogr; 1972; 52():25-31. PubMed ID: 4544612
    [No Abstract]   [Full Text] [Related]  

  • 16. Fibrin deposition in the ribbit kidney produced by protease inhibitors.
    Beller FK; Mitchell PS; Gorstein F
    Thromb Diath Haemorrh; 1967 May; 17(3-4):427-39. PubMed ID: 5301528
    [No Abstract]   [Full Text] [Related]  

  • 17. The biochemistry of the fibrinolytic enzyme system in man.
    Rickli EE
    Angiologica; 1968; 5(2):66-79. PubMed ID: 4232516
    [No Abstract]   [Full Text] [Related]  

  • 18. Effect of para-aminomethylbenzoic acid on the post-irradiation disturbance of haemocoagulation in dogs after whole-body exposure to 600 R.
    Pospísil J; Skala E; Vranovská J; Dienstbier Z
    Strahlentherapie; 1972 Dec; 144(6):728-36. PubMed ID: 4567740
    [No Abstract]   [Full Text] [Related]  

  • 19. [The inhibitors of fibrinolysis: new information on antifibrinolytic agents].
    Giacomazzi G
    Haematologica; 1968; 53(7):489-533. PubMed ID: 4976851
    [No Abstract]   [Full Text] [Related]  

  • 20. [Comparative studies on the antifibrinolytic effect (in vitro and in vivo) of t-AMCHA, phenyl-t-AMCHA, trasylol].
    Moriguchi S
    Nihon Seirigaku Zasshi; 1971; 33(6):355-63. PubMed ID: 5315192
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.